Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. As researchers and healthcare professionals work tirelessly to improve the lives of those affected, the landscape of DMD treatment has evolved significantly in recent years. Various medications aim to slow disease progression, improve muscle function, and enhance overall quality of life. From corticosteroids to newer gene therapies, these advancements represent hope for families and patients navigating the challenges of DMD. Understanding these treatments is crucial for maximizing their potential benefits and improving outcomes for those living with this condition.
|
|
|
|
